This critical review evaluates progress toward viable point-of-care protein biomarker
measurements for cancer detection and diagnostics. The ability to measure panels of …

The focus of this article is to review the recent advances in proteome analysis of human
body fluids, including plasma/serum, urine, cerebrospinal fluid, saliva, bronchoalveolar …

The objective of this study was to review and summarise the published evidence for an
association between circulating concentrations of C reactive protein (CRP) and cancer …

Our aim was to systematically review the epidemiologic evidence for an association of
circulating interleukin-6 (IL-6), an inflammatory cytokine and cancer. We systematically …

The effective implementation of personalized cancer therapeutic regimens depends on the
successful identification and translation of informative biomarkers to aid clinical decision …

Antibody arrays are valuable for the parallel analysis of multiple proteins in small sample
volumes. The earliest and most widely used application of antibody arrays has been to …

Traumatic brain injury (TBI) is the leading cause of death and disability among young adults.
Numerous safety improvements in the workplace, the addition of airbags to vehicles, and the …

Pancreatic cancer is an aggressive disease with poor prognosis, due, in part, to the lack of
disease-specific biomarkers that could afford early and accurate diagnosis. With a …

The application of protein biomarkers as an aid for the detection and treatment of diseases
has been subject to intensified interest in recent years. The quantitative assaying of protein …

Antibody-based microarray is a novel proteomic technology setting a new standard for
molecular profiling of non-fractionated complex proteomes. The first generation of antibody …